Formulation (Injectable)

Formulation (Injectable)

Our newest state-of-the-art formulation development and manufacturing facility is commissioned in March' 2025 and spans across 36,441 m² based in Valthera, Gujarat. The facility is dedicated to manufacturing injectable dosage forms. This cutting-edge facility is capable of producing a variety of delivery forms, including liquid and lyophilized vials, dry powder injections, and sterile lyophilize powders. It has state-of-the-art manufacturing equipment built with a high degree of automation.

The manufacturing facility is designed as per global regulatory standards and fully compliant with cGMPs. Inspection by US Food & Drug Administration (US FDA) is pending.